113 related articles for article (PubMed ID: 25836746)
1. A homogenizing process of selection has maintained an "ultra-slow" acetylation NAT2 variant in humans.
Patillon B; Luisi P; Poloni ES; Boukouvala S; Darlu P; Genin E; Sabbagh A
Hum Biol; 2014; 86(3):185-214. PubMed ID: 25836746
[TBL] [Abstract][Full Text] [Related]
2. Population genetic diversity of the NAT2 gene supports a role of acetylation in human adaptation to farming in Central Asia.
Magalon H; Patin E; Austerlitz F; Hegay T; Aldashev A; Quintana-Murci L; Heyer E
Eur J Hum Genet; 2008 Feb; 16(2):243-51. PubMed ID: 18043717
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes.
Patin E; Barreiro LB; Sabeti PC; Austerlitz F; Luca F; Sajantila A; Behar DM; Semino O; Sakuntabhai A; Guiso N; Gicquel B; McElreavey K; Harding RM; Heyer E; Quintana-Murci L
Am J Hum Genet; 2006 Mar; 78(3):423-36. PubMed ID: 16416399
[TBL] [Abstract][Full Text] [Related]
4. Arylamine N-acetyltransferase 2 (NAT2) genetic diversity and traditional subsistence: a worldwide population survey.
Sabbagh A; Darlu P; Crouau-Roy B; Poloni ES
PLoS One; 2011 Apr; 6(4):e18507. PubMed ID: 21494681
[TBL] [Abstract][Full Text] [Related]
5. Polymorphic NATs and cancer predisposition.
Hirvonen A
IARC Sci Publ; 1999; (148):251-70. PubMed ID: 10493262
[TBL] [Abstract][Full Text] [Related]
6. Variation in NAT2 acetylation phenotypes is associated with differences in food-producing subsistence modes and ecoregions in Africa.
Podgorná E; Diallo I; Vangenot C; Sanchez-Mazas A; Sabbagh A; Černý V; Poloni ES
BMC Evol Biol; 2015 Dec; 15():263. PubMed ID: 26620671
[TBL] [Abstract][Full Text] [Related]
7. Study on Genotyping Polymorphism and Sequencing of N-Acetyltransferase 2 (NAT2) among Al-Ahsa Population.
Zahra MA; Kandeel M; Aldossary SA; Al-Taher A
Biomed Res Int; 2020; 2020():8765347. PubMed ID: 32626768
[TBL] [Abstract][Full Text] [Related]
8. Genotype and allele frequencies of N-acetyltransferase 2 and glutathione S-transferase in the Iranian population.
Torkaman-Boutorabi A; Hoormand M; Naghdi N; Bakhshayesh M; Milanian I
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1207-11. PubMed ID: 17880378
[TBL] [Abstract][Full Text] [Related]
9. Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.
Selinski S; Blaszkewicz M; Ickstadt K; Hengstler JG; Golka K
Arch Toxicol; 2013 Dec; 87(12):2129-39. PubMed ID: 24221535
[TBL] [Abstract][Full Text] [Related]
10. Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: effects of 7 specific NAT2 nucleic acid substitutions.
Hein DW; Doll MA; Rustan TD; Ferguson RJ
Cancer Res; 1995 Aug; 55(16):3531-6. PubMed ID: 7627960
[TBL] [Abstract][Full Text] [Related]
11. The differential effect of NAT2 variant alleles permits refinement in phenotype inference and identifies a very slow acetylation genotype.
Ruiz JD; Martínez C; Anderson K; Gross M; Lang NP; García-Martín E; Agúndez JA
PLoS One; 2012; 7(9):e44629. PubMed ID: 22970273
[TBL] [Abstract][Full Text] [Related]
12. Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles.
Ferguson RJ; Doll MA; Rustan TD; Gray K; Hein DW
Drug Metab Dispos; 1994; 22(3):371-6. PubMed ID: 7915226
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphism in N-Acetyltransferase (NAT): Population distribution of NAT1 and NAT2 activity.
Walker K; Ginsberg G; Hattis D; Johns DO; Guyton KZ; Sonawane B
J Toxicol Environ Health B Crit Rev; 2009; 12(5-6):440-72. PubMed ID: 20183529
[TBL] [Abstract][Full Text] [Related]
14. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
Grant DM; Blum M; Beer M; Meyer UA
Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
[TBL] [Abstract][Full Text] [Related]
15. [Comparative analysis of N-acetylation polymorphism in humans as determined by phenotyping and genotyping].
Goldenkova-Pavlova IV; Bruskin SA; Abdeev RM; Markarova EV; Bigvava SG; Radkevich LA; Kozhekbaeva ZhM; Glotov AS; Gra OA; Zasedatelev AS; Nasedkina TV; Kurdanov KhA; Piruzian ES
Genetika; 2006 Aug; 42(8):1143-50. PubMed ID: 17025166
[TBL] [Abstract][Full Text] [Related]
16. Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populations.
Deloménie C; Sica L; Grant DM; Krishnamoorthy R; Dupret JM
Pharmacogenetics; 1996 Apr; 6(2):177-85. PubMed ID: 9156695
[TBL] [Abstract][Full Text] [Related]
17. A slow acetylator genotype associated with an increased risk of advanced cervical cancer.
Costa S; Medeiros R; Vasconcelos A; Pinto D; Lopes C
J Cancer Res Clin Oncol; 2002 Dec; 128(12):678-82. PubMed ID: 12474054
[TBL] [Abstract][Full Text] [Related]
18. Analysis of six SNPs of NAT2 in Ngawbe and Embera Amerindians of Panama and determination of the Embera acetylation phenotype using caffeine.
Jorge-Nebert LF; Eichelbaum M; Griese EU; Inaba T; Arias TD
Pharmacogenetics; 2002 Jan; 12(1):39-48. PubMed ID: 11773863
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes.
Hein DW; Doll MA
Pharmacogenomics; 2012 Jan; 13(1):31-41. PubMed ID: 22092036
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of genetic polymorphisms of drug metabolism.
Meyer UA; Zanger UM
Annu Rev Pharmacol Toxicol; 1997; 37():269-96. PubMed ID: 9131254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
